Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
As EV adoption accelerates and supply chains stabilize, a select group of automakers stand out as potential leaders a...
Rocket Lab’s stock faced a sharp pullback before rebounding in March. This article breaks down what caused the drop, ...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
As earnings season arrives, smart investors are drilling into Transcat's 2026 earnings outlook. This guide breaks dow...
Procter & Gamble anchors the dividend-growth crowd with a multi-decade streak and strong cash flow. The plain-as-day ...
A prominent analyst argues SpaceX could surge, but practical hurdles and private-market realities temper the enthusia...
Wall Street is split on two big AI chips players: Intel and Marvell. One stock is riding optimism about data-center d...
A trio of midstream dividend ETFs yielding more than 5% are delivering market-beating performance, offering both inco...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...